Press Releases | ARUP Laboratories

Press Releases

Magnify Magazine

Media Resources

Press Releases

microscope

Magnify Magazine

microscope

Media Resources

microscope

ARUP’s great culture is getting noticed. Thanks to our dedicated employees for putting us on the Forbes magazine list of America’s Best Midsize Employers for 2022.	February 11, 2022	ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list of America’s Best Midsize Employers for 2022.
	December 8, 2021	ARUP Earns Fourth Consecutive Utah Business Best Companies to Work For Award For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For award. ARUP is one of 65 companies to earn the award.
Whole genome HiFi sequencing will be used on unexplained rare disease cases to evaluate if it can identify variants not readily detectable by short-read sequencing.	November 18, 2021	PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis PacBio and ARUP Laboratories announced they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased.
	November 12, 2021	Recycling Coalition of Utah Names ARUP the Thomas A. Martin Business Recycler of the Year The Recycling Coalition of Utah (RCU) honored ARUP with its Thomas A. Martin Business Recycler of the Year Award in recognition of the company’s recycling program efforts.
	October 26, 2021	ARUP Increases Its Minimum Hourly Wage to $15 and Raises Pay for All Hourly Employees ARUP Laboratories announced that it will increase its minimum hourly wage to $15 , marking an important milestone in the company’s multiyear effort to increase wages for all employees.
President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.	July 2, 2021	ARUP’s Clinical Trials Group Lauds FDA Approval of New Precision The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.